Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181207 · ClinicalTrials.gov registry record · Phase 4
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
A Phase 4 study of COPD and Emphysema, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00181207 is a Phase 4 study of COPD and Emphysema that has completed, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00181207, a Phase 4 study of COPD and Emphysema, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to show that one form of mechanical airway clearance techniques, High Frequency Chest Wall Oscillation (HFCWO)using a pneumatic vest, will diminish exacerbations of COPD which will improve respiratory health status.
Conditions Studied
Interventions
- DEVICE pneumatic vest
- OTHER placebo pneumatic vest
Study Locations (1)
Maryland
- Johns Hopkins Asthma and Allergy Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181207
The ClinicalTrials.gov registry entry for NCT00181207 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which pneumatic vest is the first listed.
NCT00181207 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00181207 about?
NCT00181207 is a clinical study titled "Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation". The purpose of this study is to show that one form of mechanical airway clearance techniques, High Frequency Chest Wall Oscillation (HFCWO)using a pneumatic vest, will diminish exacerbations of COPD which will improve respiratory health status.
What is the current status of trial NCT00181207?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2004-05. Estimated completion is 2007-12.
What conditions does trial NCT00181207 study?
This clinical trial studies the following conditions: COPD, Emphysema, Chronic Bronchitis.
What interventions are being tested in trial NCT00181207?
The interventions under investigation include: pneumatic vest (DEVICE), placebo pneumatic vest (OTHER).
Who is sponsoring clinical trial NCT00181207?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00181207 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
COMPLETED · Phase 4
-
Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients
COMPLETED · Phase 4
-
Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)
COMPLETED · Phase 4
-
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.